Key result
IABP use in acute MI is linked to ~20% in-hospital mortality.
Why the study?
The current indications, associated complications, and clinical outcomes of intra-aortic balloon pump use in acute myocardial infarction are unknown despite broadened indications and increased experience.
What are the contemporary utilization patterns and clinical outcomes of intra-aortic balloon pump counterpulsation in patients with acute myocardial infarction?
Observational (n=5,495)
Yes
What are the contemporary utilization patterns and clinical outcomes of intra-aortic balloon pump counterpulsation in patients with acute myocardial infarction?
No takes yet. Share an insight, caveat, or question.
In a large, contemporary, worldwide registry, IABP counterpulsation in AMI patients was associated with a high insertion success rate and a low major complication rate, despite the high-risk nature of the population.
Stone et al. (2003) conducted an observational in Acute myocardial infarction (AMI) requiring intra-aortic balloon pump (IABP) counterpulsation (n=5,495). Intra-aortic balloon pump (IABP) counterpulsation was evaluated on In-hospital mortality. Intra-aortic balloon pump counterpulsation in acute myocardial infarction was associated with a 20.0% in-hospital mortality rate and a 2.7% major complication rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: